explore -WSS

explore

author：Wikipedia 2025-09-07 04:09:56 - browse：5298

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： With fresh data, a dynamic duo powers Eli Lilly to new heights

WSS

Titanic submersible: What a 'catastrophic implosion' means and what officials found

North Korean leader's powerful sister says warplanes repelled US spy plane

Vertex non

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Woodcock on FDA’s accelerated approval and her next chapter

Vertigo drug brings hope for rare neuron disorder, Niemann

entertainment

explore

explore

Supreme Court strikes down use of affirmative action

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

ChatGPT in medicine: STAT answers readers' burning questions

New Ultima Genomics DNA sequencer can read genome for $100

Hepatitis C has a cure — but many Americans still lack access to it

Drinking water from half of US faucets contains PFAS: Study

In age of alternative facts, a scholarly course on calling out crap

California man arrested in connection with serial murders of Mexican strip club workers

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA drug safety: Singulair case shows systemic surveillance flaws

hotspot

Cognito secures funding to test medical device for Alzheimer's

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Congressmen charge Covid hearing ‘could have been an email’

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

focus

focus

entertainment

entertainment